On
Oncorus (sold)
Cambridge MAFounded 201550 employees
Private CapbiotechAcquiredOncology
Platform: oHSV Synthetic
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Motafutibatinib | ONC-1480 | Approved | 3 | KIF18A | MesoGBM | ||
| Talafotisoran | ONC-9474 | NDA/BLA | 1 | PSMA | MigraineOvarian Ca | ||
| Peminesiran | ONC-5204 | Phase 1 | 2 | TIGIT | EpilepsyObesity |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (6)